[Elsevier] Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trial |
Reward10points
|
| |
10
Comprehensive investigation on ballistic injection characteristics of GDI injector: A particular focus on injection pressure and fuel effects
20
[SSRN] A General Theory of Coolness
20
[SSRN] A Supreme Case of Coolness?
10
HOG transformation based feature extraction framework in modified Resnet50 model for brain tumor detection
10
Climate risks and vulnerabilities of the Arabica coffee in Brazil under current and future climates considering new CMIP6 models
